SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-17-002946
Filing Date
2017-11-13
Accepted
2017-11-13 17:26:33
Documents
3
Period of Report
2017-11-13
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K peregrine_8k.htm 8-K 24084
2 PRESS RELEASE peregrine_8k-ex9901.htm EX-99.1 7237
3 GRAPHIC logo.jpg GRAPHIC 5020
  Complete submission text file 0001683168-17-002946.txt   39703
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-32839 | Film No.: 171197272
SIC: 2834 Pharmaceutical Preparations